US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

34.72

0.0000

Volume:18

Turnover:623.49

Market Cap:2.60M

PE:- -

High:34.72

Open:34.72

Low:34.72

Close:34.72

52wk High:36.54

52wk Low:23.88

Shares:75.00K

Float Shares:75.00K

Volume Ratio:0.31

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Thermo Fisher Exec Says Academic and Government Research Market Should Return to Growth in 2027 - Morgan Stanley Conference

THOMSON REUTERS

Thermo Fisher Exec Says Orders are Outpacing Revenue, Boding Well for Future Growth- Morgan Stanley Conference

THOMSON REUTERS

Mayo Clinic and Thermo Fisher Scientific Launch Precure, Llc to Identify Signs of Disease Before Symptoms Appear

THOMSON REUTERS

Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

Barclays downgrades Scholar Rock on valuation after FDA approval

Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20

Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics

Guardant Health, - Evicore by Evernorth to Cover Shield Blood Test for Crc Screening Effective Jan 1, 2027

THOMSON REUTERS

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Scholar Rock Wins FDA Approval for SMA Therapy

Scholar Rock price target raised to $84 from $76 at BMO Capital

Cellectis pivots to in vivo gene editing and exits key CAR-T programs

Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company

Vertex Minerals Revises Timeline for Proposed Securities Issue

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Gap, Quanta, Thermo Fisher, LAC, First Solar Trending

Scholar Rock announces FDA approval of isembyld

Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day

IntegraGen receives rival takeover bids amid court‑ordered restructuring

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/GNMX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":34.7203,"timestamp":1789482404984,"preClose":34.7203,"halted":0,"volume":18,"delay":0,"changeRate":0,"floatShares":75000,"shares":75000,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-15 10:34:45 EDT","open":34.7203,"high":34.7203,"low":34.7203,"amount":623.485926,"amplitude":0,"askPrice":34.56,"askSize":1100,"bidPrice":34.49,"bidSize":1100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":34.7203,"nav":34.12,"aum":2559000,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.1467,"preClose":34.7203,"latestTime":"16:10 EDT","volume":6,"amount":208.3218,"timestamp":1789416603776,"change":-0.5736,"changeRate":-0.016521,"amplitude":0},"volumeRatio":0.313771,"impliedVol":0.2416,"impliedVolPercentile":0.4268},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":75000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.313771,"shares":75000,"dividePrice":0,"high":34.7203,"amplitude":0,"preClose":34.7203,"low":34.7203,"week52Low":23.88,"pbRate":"--","week52High":36.5366,"institutionHeld":0,"latestPrice":34.7203,"eps":0,"divideRate":0,"volume":18,"delay":0,"ttmEps":0,"open":34.7203,"prevYearClose":25.56,"prevWeekClose":34.1467,"prevMonthClose":35.0802,"prevQuarterClose":31.0879,"fiveDayClose":34.8,"twentyDayClose":32.3271,"sixtyDayClose":27.4225},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNMX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667628546","title":"Thermo Fisher Exec Says Academic and Government Research Market Should Return to Growth in 2027 - Morgan Stanley Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628546?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:59","pubTimestamp":1789480777,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570G6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1291159041.SGD","LU2211814178.USD","LU0251142724.SGD","LU1803068623.USD","LU2125909247.SGD","IE0034235188.USD","LU1720051017.SGD","IE00B19Z9505.USD","LU0345770993.USD","LU1670628061.USD","LU2211815571.USD","BK4533","LU0266013472.USD","LU0742534661.SGD","LU1061106388.HKD","GNMX","BK4535","LU1988902786.USD","LU0528227936.USD","LU0234572021.USD","LU1023059063.AUD","LU0310800379.SGD","BK4581","IE00BJJMRZ35.SGD","TMED","LU1623119135.USD","LU1791710400.SGD","LU0708994859.HKD","LU1280957306.USD","IE00BKPKM429.USD","LU2543165471.USD","LU1854104046.USD","BK4548","HRTS","LU0316494557.USD","LU2720916845.USD","LU0320765489.SGD","LU0640476718.USD","LU0122379950.USD","LU0251131958.USD","LU1633808545.USD","LU0557290698.USD","LU1989771016.USD","TMO","FMED","IE00BFTCPJ56.SGD","LU2764262908.HKD","LU2092937221.SGD","IE00B4R5TH58.HKD","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667361628","title":"Thermo Fisher Exec Says Orders are Outpacing Revenue, Boding Well for Future Growth- Morgan Stanley Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2667361628","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667361628?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:59","pubTimestamp":1789480777,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570G6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","LU0342679015.USD","IE00BJT1NW94.SGD","LU1791710582.SGD","GNMX","LU2125909247.SGD","LU0128525929.USD","LU1670627923.USD","LU1989771016.USD","LU2298321311.HKD","LU2433249047.HKD","LU0823416689.USD","IE00B19Z9505.USD","LU1548497426.USD","BK4533","LU2041044095.USD","LU0557290698.USD","TMO","LU1670628061.USD","LU2125910179.SGD","LU2764262908.HKD","IE00BQXX3F31.USD","BK4581","TMED","LU2468319806.SGD","LU0345770993.USD","LU0234572021.USD","LU2264538146.SGD","IE0002141913.USD","LU1057294990.SGD","LU2764263039.SGD","LU1720051108.HKD","LU0061474960.USD","LU0528227936.USD","LU0345770308.USD","LU2092937221.SGD","LU2125910336.SGD","LU2063271972.USD","LU2211814178.USD","LU2764263203.CNY","LU0048573561.USD","LU2089984988.USD","FMED","LU1803068623.USD","LU1923621640.USD","HRTS","LU1267930573.SGD","LU1854104046.USD","BK4588","LU2357305700.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644412","title":"Mayo Clinic and Thermo Fisher Scientific Launch Precure, Llc to Identify Signs of Disease Before Symptoms Appear","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644412","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644412?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473607,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA9M2KLH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","LU2041044095.USD","LU0316494557.USD","HRTS","LU2764263203.CNY","GNMX","LU2125909593.SGD","TMED","LU2720916845.USD","IE0009355771.USD","LU2125910336.SGD","LU2063271972.USD","IE00BJJMRZ35.SGD","LU0029864427.USD","LU0266013472.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU2264538146.SGD","LU1023059063.AUD","LU1815333072.USD","LU1064131342.USD","TMO","LU1983299246.USD","LU2298321311.HKD","LU1988902786.USD","LU0048573561.USD","LU1633808545.USD","LU1623119135.USD","IE00BQXX3D17.EUR","LU1803068623.USD","LU0251142724.SGD","LU0310800379.SGD","FMED","LU1670627923.USD","LU0432979614.USD","LU1720051017.SGD","LU0345770308.USD","BK4535","LU1720051108.HKD","LU1923622291.USD","LU2089984988.USD","GB00BDT5M118.USD","LU1153585028.USD","LU0208291251.USD","LU2211814178.USD","LU1548497426.USD","LU0345770993.USD","IE00B4R5TH58.HKD","IE0034235188.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644589","title":"Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644589?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:36","pubTimestamp":1789472175,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) has partnered with world champion skier Lindsey Vonn to raise awareness of JOURNAVX, a prescription non-opioid medici...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-partners-with-lindsey-vonn-for-journavx-awareness-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-partners-with-lindsey-vonn-for-journavx-awareness-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","BBH","IE00BJT1NW94.SGD","BK4533","PBE","LU1674673691.USD","IBBQ","LU2362541273.HKD","BK4567","IDNA","LU2362541513.USD","LU1035775433.USD","IE00B19Z9P08.USD","LU0256863811.USD","LU0757428866.USD","BK4588","SG9999001176.SGD","LU1674673428.USD","LU2456880835.USD","VERX","BK4023","IE0002141913.USD","LU1069344957.HKD","LU1430594728.SGD","IE00B19Z3B42.SGD","LU2468319806.SGD","TBXU","IE00B19Z9Z06.USD","LU2362540622.SGD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU1559883803.SGD","SG9999001176.USD","IE00BFTCPJ56.SGD","BIB","BK4532","BK4585","IBB","LU0061475181.USD","LU1585245621.USD","LU2237438978.USD","LU0566484027.USD","GNMX","LU1093756325.SGD","LU0109394709.USD","IE00B2B36J28.USD","IE0009355771.USD","LU0234570918.USD","VRTX","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641173","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641173?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:20","pubTimestamp":1789471221,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Centene (CNC), Natera (NTRA) and Vertex Pharmaceut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","LU0053671581.USD","BK4585","LU1035775433.USD","XLV","NTRA","LU0859254822.USD","CNC","LU0130518102.USD","GNMX","IBBQ","LU1291159041.SGD","HCSG","IE0002270589.USD","LU1988902786.USD","PBE","BK4023","LU0289739699.SGD","CNCG","LU0648000940.SGD","LU0823416689.USD","LU2065171311.SGD","TBXU","VRTX","BK4567","LABU","BK4139","IE0009355771.USD","IE00B19Z3581.USD","LU2236285917.USD","LU2462157665.USD","HELX","VERX","BK4137","LU1430594728.SGD","XBI","BK4581","IBB","IE00B19Z9Z06.USD","BIB","LU0234570918.USD","GNOM","LU1674673691.USD","LU0128526141.USD","BBH","LU0012050646.USD","LU2456880835.USD","LU1585245621.USD","LU2065169927.USD","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643557","title":"Barclays downgrades Scholar Rock on valuation after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643557?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:10","pubTimestamp":1789463419,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout downgraded Scholar Rock (SRRK) to Equal Weight from Overweight with a price target of $58, up from $55. The approval ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDIG","IBB","TACU","LFSC","FRTY","PINK","SYNB","TBXU","TSPA","TECB","LABU","PSCH","GNMX","MEDI","BBP","RSPH","MRNY","BMED","IYH","XLVX","IDNA","GDOC","NVIB","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667569983","title":"Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20","url":"https://stock-news.laohu8.com/highlight/detail?id=2667569983","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667569983?lang=en_us&edition=fundamental","pubTime":"2026-09-15 06:12","pubTimestamp":1789423938,"startTime":"0","endTime":"0","summary":"Guardant Health CIO Kumud Kalia disposes of 4,000 common shares worth $632,193.20Guardant Health Chief Information Officer Kumud Kalia sold 4,000 common shares on Sept. 11, 2026.The sale price was USD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL3DVtS3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GNMX","GDOC","GH","LU0320765992.SGD","BK4535","BK4551","BK4585","GNOM","LU0109394709.USD","PTH","EKG","HELX","BK4196","FFOX","LFSC","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667869541","title":"Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2667869541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667869541?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:37","pubTimestamp":1789418272,"startTime":"0","endTime":"0","summary":"Niki BioSolutions Inc ( ($NIKI) ) just unveiled an announcement. Niki BioSolutions Inc operates in the biotechnology and molecular diagnostics sect...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","HELX","RSPH","IEIH","LNGR","GNMX","DARP","BK4588","BBP","FHLC","SYNB","FWD","BMED","IBB","HTEC","XT","AGNG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667087693","title":"Guardant Health, - Evicore by Evernorth to Cover Shield Blood Test for Crc Screening Effective Jan 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2667087693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667087693?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:07","pubTimestamp":1789416443,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4560HZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4551","BK4585","GNOM","LU0109394709.USD","LU0320765992.SGD","FFOX","PTH","GH","LFSC","BK4588","HELX","BK4535","LU0889565916.HKD","GNMX","EKG","GDOC","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","IEIH","IYH","SYNB","TBXU","IDNA","FRTY","MEDI","PINK","GNMX","LABU","PSCH","RSPH","BK4007","LFSC","BK4588","IBB","BK4585","TECB","XLVX","MRNY","BFRI","GDOC","BMED","NVIB","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","IYH","MRNY","TECB","PSCH","IDNA","MEDI","PINK","BMED","SYNB","FRTY","XLVX","LABU","NVIB","BK4585","BBP","GNMX","IEIH","MRNX","LFSC","GDOC","TBXU","RSPH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","SYNB","BK4139","MRNY","SRRK","IEIH","FRTY","BK4588","BK4585","MRNX","IBRN","LFSC","IBB","GDOC","BBP","BMED","PSCH","GNMX","TECB","XLVX","THNR","NVIB","RSPH","IDNA","IYH","LABU","PINK","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667376655","title":"Cellectis pivots to in vivo gene editing and exits key CAR-T programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667376655","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667376655?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:15","pubTimestamp":1789370144,"startTime":"0","endTime":"0","summary":"Cellectis SA ( ($FR:ALCLS) ) has provided an announcement. Cellectis has approved a strategic shift to focus on in vivo gene editing, advancing two...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cellectis-pivots-to-in-vivo-gene-editing-and-exits-key-car-t-programs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cellectis-pivots-to-in-vivo-gene-editing-and-exits-key-car-t-programs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","WDNA","HELX","GNMX","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667653981","title":"Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2667653981","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667653981?lang=en_us&edition=fundamental","pubTime":"2026-09-14 14:40","pubTimestamp":1789368000,"startTime":"0","endTime":"0","summary":"Cellectis to advance two lead in vivo programs .HEAL-101 and .HEAL-201 in severe dyslipidemias with preliminary Phase 1 data planned in H2 2027 and H1 2028, respectivelyTransformation supported by con","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/14/3360712/0/en/cellectis-announces-strategic-transformation-to-in-vivo-gene-editing-company.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","GNMX","SYNB","BK4156","BK4139","IDNA","HEAL","NC","HELX","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635488","title":"Vertex Minerals Revises Timeline for Proposed Securities Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635488?lang=en_us&edition=fundamental","pubTime":"2026-09-14 07:40","pubTimestamp":1789342824,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has provided an update. Vertex Minerals Ltd. has updated its proposed securities placement timetable, revising t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","LU1674673428.USD","BK4588","IBBQ","IE00BZ9MQY76.HKD","BK4533","BK4532","IE00B4R5TH58.HKD","IDNA","LU2468319806.SGD","IE00B2B36J28.USD","SG9999001176.USD","LU2362541273.HKD","SGXZ57979304.SGD","PBE","LU0079474960.USD","IBB","BK4109","LU0234570918.USD","LU0432979614.USD","LU1815336091.USD","SG9999001176.SGD","LU1674673691.USD","LU1559883803.SGD","TBXU","IE0009355771.USD","MTX","LU0417517546.SGD","GNMX","IE00B19Z9P08.USD","LU0061475181.USD","BIB","IE00B894F039.SGD","LU1430594728.SGD","LU1093756325.SGD","LU0889565916.HKD","LU0566484027.USD","LU0058720904.USD","LU0757428866.USD","LU2462157665.USD","IE00BJT1NW94.SGD","LU1585245621.USD","LU0320765992.SGD","VERX","BK4585","IE00BJJMRZ35.SGD","LU0256863811.USD","BBH","VRTX","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","XLVX","MRNY","PSCH","IYH","BMED","FRTY","BK4588","IDNA","IEIH","SYNB","GDOC","RSPH","TECB","LFSC","GNMX","BK4585","BK4139","NVIB","LABU","PINK","TLX","MEDI","FET","TBXU","BBP","MRNX","BK4179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666060795","title":"Gap, Quanta, Thermo Fisher, LAC, First Solar Trending","url":"https://stock-news.laohu8.com/highlight/detail?id=2666060795","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666060795?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:01","pubTimestamp":1789203687,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($GAP) ), ( ($PWR) ), ( ($TMO) ), ( ($LAC) ) and ( ($FSLR) ). Here is a breakdown of their recent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/gap-quanta-thermo-fisher-lac-first-solar-trending?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/gap-quanta-thermo-fisher-lac-first-solar-trending?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0061474960.USD","LU0345770993.USD","BK4121","LU0154245673.USD","LU1992135472.HKD","LU0122379950.USD","LU0266013472.USD","VCLN","LU0742534661.SGD","LU2063271972.USD","BK4585","IE00B2PGVK34.USD","SMOG","IE0002141913.USD","IE0009355771.USD","LU0154245756.USD","LU2298321311.HKD","LU2125909916.SGD","GAP","LU0208291251.USD","LU2543165471.USD","IE00B4R5TH58.HKD","LU1791710400.SGD","LU0823434740.USD","LU1670628061.USD","LU1923622291.USD","LU0320765489.SGD","IE0034235188.USD","BK4566","LAC","LU2023250504.SGD","LU2041044095.USD","LU2106854487.HKD","LU2272731600.USD","LU0251142724.SGD","CTEC","LU2468319806.SGD","LU0724618433.USD","LU0323239441.USD","LU0640476718.USD","LU2433249047.HKD","TMED","LU1023059063.AUD","LU1791710582.SGD","BK4588","LU0823434583.USD","LU1280957306.USD","LU1989771016.USD","LU2125909247.SGD","LU2764263039.SGD","LU2322448791.USD","IE00BJT1NW94.SGD","LU0432979614.USD","BK4094","IE00B19Z8X17.USD","LU1720051108.HKD","LU0823421333.USD","TMO","LU1291159041.SGD","LITP","LU0557290698.USD","LU2357125470.USD","LU1988902786.USD","IE00B19Z9505.USD","LU1712237335.SGD","FSLR","HRTS","LU0114720955.EUR","LU0823416689.USD","LU1670627923.USD","LU2272731865.HKD","LU1153585028.USD","TAN","LU1923621640.USD","LU2125910336.SGD","BK4533","ILIT","LU0124384867.USD","LU2764263203.CNY","IE00BGHQF417.EUR","LU2272731782.SGD","LU2473716301.USD","LU1064131342.USD","LU0957791311.USD","IE00B2B36J28.USD","LU2249611893.SGD","IE00BFTCPJ56.SGD","LU0823421416.USD","LU0528227936.USD","BK4141","BK4168","BK4581","LU1057294990.SGD","BK4534","LU2360108059.USD","LU2089984988.USD","LU2720916845.USD","IE00B19Z8W00.USD","IE00BQXX3F31.USD","LU1061106388.HKD","LU2294711713.HKD","LU2322448957.HKD","LU2357305700.SGD","ICLN","LU1854104046.USD","LU0234572021.USD","LU0823414551.USD","IE00BJJMRZ35.SGD","BK4519","LU1267930573.SGD","LU2048586759.USD","LU1983299246.USD","LU0342679015.USD","LU2125909593.SGD","LU1854103824.USD","LU1983299162.USD","GB00BDT5M118.USD","LU0345770308.USD","LU2764262908.HKD","LU2125909759.SGD","BK4596","LU1803068623.USD","LU1720051017.SGD","FMED","LU0316494557.USD","LU0823414478.USD","LU0048573561.USD","LU2264538146.SGD","LU0070302665.USD","BK4545","LU0128525929.USD","LU2211814178.USD","LU0096362180.USD","IE00BQXX3C00.GBP","LU2298322129.HKD","BK4535","LU1917777945.USD","LU2125910179.SGD","GNMX","LU1978683503.SGD","IE00B1BXHZ80.USD","LU0323240290.USD","LU1974910355.USD","LU0011850046.USD","LU1548497426.USD","LU1623119135.USD","IE00BQXX3D17.EUR","LU0029864427.USD","LU1815333072.USD","LU0251131958.USD","FRNW","LU1992135399.USD","LU2112291526.USD","LU2506951792.HKD","LU1633808545.USD","LU1923622614.USD","LU0310800379.SGD","LU0312595415.SGD","BK4548","LU0882574055.USD","LACG","IE00B3CCJ633.GBP","LU0708994859.HKD","IE00BKPKM429.USD","LU2092937221.SGD","LU2211815571.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","THNR","RSPH","IBB","MRNX","PSCH","IBRN","NVIB","SRRK","IYH","BK4588","SYNB","PINK","LABU","BMED","TECB","BK4585","FRTY","LFSC","MRNY","TBXU","XLVX","MEDI","GDOC","GNMX","IEIH","IDNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666957448","title":"Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666957448","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666957448?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:53","pubTimestamp":1789159980,"startTime":"0","endTime":"0","summary":"DJ Agilent Technologies Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Agilent Technologies Inc.  rose 2.66% to $146.93 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.86% to 7,656.98 and the Dow Jones Industrial Average  rising 0.98% to 52,573.29.The stock's rise snapped a three-day losing streak.Agilent Technologies Inc. closed 10.27% short of its 52-week high of $163.75, which the company reached on August 27th.The stock outperformed some of its competitors Friday, as Thermo Fisher Scientific Inc.  rose 1.10% to $609.82, Danaher Corp.  fell 0.19% to $200.14, and Abbott Laboratories  fell 1.36% to $101.95.Trading volume  remained 382,080 below its 50-day average volume of 2.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","LU1974910355.USD","LU0320765059.SGD","LU1551013342.USD","LU1691799644.USD","ABT","IHI","LU1914381329.SGD","LU1988902786.USD","LU0175139822.USD","LU1815333072.USD","LU0187121727.USD","A","IE0004445239.USD","LU2413666699.HKD","BK4567","GNMX","LU0390134368.USD","FMED","LU1165135440.EUR","BK4585","BK4533","LU1623119135.USD","LU0708995401.HKD","BK4082","LU0266013472.USD","IE00BJJMRZ35.SGD","LU0943347566.SGD","LU0820561909.HKD","HRTS","LU2264538146.SGD","LU0672654240.SGD","LU0689472784.USD","IE00BQXX3D17.EUR","IE00B4R5TH58.HKD","TMO","LU1280957306.USD","LU0122379950.USD","LU2041044095.USD","LU1791710400.SGD","LU1064131342.USD","PJP","TMED","LU0347712357.USD","BK4588","LU1854103824.USD","LU1543694498.USD","LU1804176565.USD","LU1721429741.USD","DHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666579410","title":"IntegraGen receives rival takeover bids amid court‑ordered restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=2666579410","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666579410?lang=en_us&edition=fundamental","pubTime":"2026-09-12 03:02","pubTimestamp":1789153348,"startTime":"0","endTime":"0","summary":"IntegraGen SA ( ($FR:ALINT) ) has provided an update. IntegraGen SA, a French genomics company focused on cancer and rare genetic diseases, provide...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/integragen-receives-rival-takeover-bids-amid-courtordered-restructuring?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/integragen-receives-rival-takeover-bids-amid-courtordered-restructuring?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","TARK","FWD","PBE","GNMX","DARP","GNOM","BMED"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}